MedTrace Logo

Recovery and Quality of Life in Cervical Cancer Patients Using Vaginal Dilators After Radiotherapy

NCT07698795 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 67

Last updated 2026-07-13

No results posted yet for this study

Summary

The goal of this longitudinal observational study is to understand the trajectory of Quality of Life (QoL) recovery in women with cervical cancer who have received definitive radiation therapy. The main questions it aims to answer are:

Do functional domains, such as physical, role, and social functioning, show significant and sustained improvement over the 12 months following treatment? How does the burden of treatment-related symptoms, including fatigue, nausea, and cervical cancer-specific symptoms, resolve during the one-year recovery period? Researchers will analyze changes in QoL scores over time to identify which clinical factors-such as time elapsed since treatment and baseline disease stage-serve as the most significant predictors of a patient's overall well-being.

Participants will:

* Complete standardized Quality of Life assessments using the EORTC QLQ-C30 and the cervical cancer-specific QLQ-CX24 instruments.
* Provide data at six specific intervals: baseline (pre-treatment) and at 1, 3, 6, 9, and 12 months post-radiotherapy.
* Report on multiple functional scales, including physical, role, emotional, cognitive, and social status.
* Monitor and report symptom levels for various issues such as fatigue, pain, nausea, and sexual/vaginal functioning.

Conditions

  • Cervical Cancer Radiation Complications
  • QoL

Sponsors & Collaborators

  • Chulabhorn Cancer Center

    lead OTHER

Principal Investigators

  • Saengrawee Thanthong, PhD · Chulabhorn Royal Academy

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-03
Primary Completion
2022-04-30
Completion
2022-04-30

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07698795 on ClinicalTrials.gov